Transparent Thinking Blog

TrialAssure cubes divider
Health Canada Clinical Trials Database PRCI services solutions redaction anonymization anonymisation trialassure support help expert

REGISTRY SNAPSHOT: Health Canada’s Clinical Trials Database

Read More

This week in transparency news: March 2 – March 15, 2019

Read More
European Database on Medical Devices (EUDAMED) The European Union Electronic Register of Post-Authorization Studies (EU PAS Register) clinical trial data reporting transparency disclosure trialassure services solutions tech

REGISTRY SNAPSHOT: The European Union Electronic Register of Post-Authorization Studies (EU PAS Register)

Read More
european union clinical trials register trialassureclinical trial reporting clinical trial reporting

REGISTRY SNAPSHOT: European Union Clinical Trials Register (EUCTR)

Read More
trialassure clinical trial transparency news

This week in transparency news: February 23 – March 1, 2019

Read More
clinical trial disclosure transparency pharma biotech medical device fda ema health canada prci data anonymization document redaction services solutions technology expert patient engagement plain language summary lay summary

Groundbreaking Transparency Application that Anonymizes Patient Data in Clinical Trials Launched by TrialAssure

Read More
Cuban Public Registry of Clinical Trials services help solutions regulation compliance trialassure technology solutions expert

REGISTRY SNAPSHOT: Cuban Public Registry of Clinical Trials

Read More

This week in transparency news: February 16 – February 22, 2019

Read More
clinicaltrials.gov ct.gov fda clinical trial registry disclosure transparency services solutions trialassure technology clinical trials

REGISTRY SNAPSHOT: ClinicalTrials.gov

Read More
Should people share their DNA for drug development purposes? – USA Today Many people don’t realize that sharing a DNA sample with Ancestry.com, 23andMe and others can result in their data being shared. However, this week, the companies pledged that they would disclose when data is shared with corporations or the government. With a $300 million investment by GSK in 23andMe, they state that approximately 80 percent of customers have agreed to share their DNA data. This data is being de-identified before it is shared.

This week in transparency news: February 9 – February 15, 2019

Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.